Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.10.2018 | Clinical study

Unapproved pharmaceutical ingredients in dietary supplements

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Potentially harmful active pharmaceuticals are commonly identified in dietary supplements, according to study results reported in JAMA Network Open, despite warnings by the US Food and Drug Administration (FDA). …
Literatur
1.
Zurück zum Zitat Tucker J, et al. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. JAMA Network Open 1: e183337, No. 6, 12 Oct 2018. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2018.3337. Tucker J, et al. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. JAMA Network Open 1: e183337, No. 6, 12 Oct 2018. Available from: URL: http://​dx.​doi.​org/​10.​1001/​jamanetworkopen.​2018.​3337.​
2.
Zurück zum Zitat Cohen PA. The FDA and Adulterated Supplements - Dereliction of Duty. JAMA Network Open 1: e183329, No. 6, 12 Oct 2018. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2018.3329 Cohen PA. The FDA and Adulterated Supplements - Dereliction of Duty. JAMA Network Open 1: e183329, No. 6, 12 Oct 2018. Available from: URL: http://​dx.​doi.​org/​10.​1001/​jamanetworkopen.​2018.​3329
Metadaten
Titel
Unapproved pharmaceutical ingredients in dietary supplements
Publikationsdatum
01.10.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-53353-5

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Enbucrilate

Case report

BCG

Case report

Acetazolamide